Camille Schiffler

655 total citations · 1 hit paper
24 papers, 385 citations indexed

About

Camille Schiffler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Camille Schiffler has authored 24 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Camille Schiffler's work include Sarcoma Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (3 papers) and Cardiac tumors and thrombi (3 papers). Camille Schiffler is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (3 papers) and Cardiac tumors and thrombi (3 papers). Camille Schiffler collaborates with scholars based in France, Switzerland and United Kingdom. Camille Schiffler's co-authors include Sylvie Chabaud, Jean‐Yves Blay, Vincent Vidal, Elsa Kalbacher, Nicolas Penel, Christine Chevreau, Corinne Delcambre, Emmanuelle Bompas, Florence Duffaud and Corinne Bouvier and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Camille Schiffler

23 papers receiving 384 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

2018 229 citations Florence Duffaud, Olivier Mir et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Camille Schiffler

Since Specialization

Citations

This map shows the geographic impact of Camille Schiffler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Schiffler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Schiffler more than expected).

Fields of papers citing papers by Camille Schiffler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Schiffler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Schiffler. The network helps show where Camille Schiffler may publish in the future.

Co-authorship network of co-authors of Camille Schiffler

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Schiffler. A scholar is included among the top collaborators of Camille Schiffler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Schiffler. Camille Schiffler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial 2024 ·BMC Cancer ·Hwayoung Noh, Amélie Anota, (unknown), (unknown), (unknown), Camille Schiffler, (unknown), Sabina Rinaldi, Joël Lachuer, Pekka Keski‐Rahkonen, Marc J. Gunter, Aude Fléchon, Béatrice Fervers, Olivia Pérol	2
2	Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial 2024 ·Clinical Cancer Research ·(unknown), C. Terret, Camille Schiffler, (unknown), Hélène Vanacker, (unknown), (unknown), Armelle Vinceneux, Lauriane Eberst, (unknown), Gwenaële Garin, (unknown), David Pérol, Yenkel Grinberg‐Bleyer, Philippe A. Cassier	3
3	p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane 2024 ·British Journal of Cancer ·Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bièche, Mario Campone, Anne Patsouris, Mónica Arnedos, Paul Cottu, Jean-Philippe Jacquin, Florence Dalenc, (unknown), Nicolas Servant, Valéry Attignon, Étienne Rouleau, Alain Morel, (unknown), Marta Jimenez, Fabrice André, Thomas Bachelot	0
4	“Mid-P strategy” versus “internal target volume strategy in locally advanced non small cell lung cancer: Clinical results from the randomized non-comparative phase II study Mid-P 2024 ·Radiotherapy and Oncology ·L. Claude, Camille Schiffler, (unknown), (unknown), (unknown), Isabelle Martel‐Lafay, Thomas Baudier, Simon Rit, David Sarrut, (unknown)	1
5	VP3-2024: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse 2024 ·Annals of Oncology ·Axel Le Cesne, Camille Schiffler, Olivier Bouché, Mehdi Brahmi, (unknown), Maud Toulmonde, B. Landi, (unknown), Diane Pannier, Emmanuelle Bompas, François Bertucci, L. Chaigneau, Olivier Collard, Marc Pracht, Antoine Adenis, Isabelle Ray‐Coquard, (unknown), Sylvie Chabaud, David Pérol, Jean‐Yves Blay	1
6	Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study 2023 ·ESMO Open ·Axel Le Cesne, Christine Chevreau, Christophe Perrin, Antoîne Italiano, Alice Hervieu, Jean‐Yves Blay, Sophie Piperno‐Neumann, Esma Saâda-Bouzid, François Bertucci, Nelly Firmin, Elsa Kalbacher, (unknown), Camille Schiffler, (unknown), Marta Jimenez, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Florence Duffaud	9
7	LBA22 Connected device and therapeutic patient education to promote physical activity among in women with localized breast cancer: Results from the DISCO randomized trial 2023 ·Annals of Oncology ·Béatrice Fervers, (unknown), Thierry Durand, David Pérol, Camille Schiffler, (unknown), Lionel Perrier, Marie Préau, Thomas Bachelot, Pierre-Étienne Heudel, C. Faure, Mellie Heinemann, (unknown), (unknown), (unknown), (unknown), Julien Grenier, Olivier Trédan, Jean‐Yves Blay, Olivia Pérol	1
8	Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study 2023 ·British Journal of Cancer ·Florence Duffaud, Jean‐Yves Blay, Axel Le Cesne, Christine Chevreau, Pascaline Boudou‐Rouquette, Elsa Kalbacher, Nicolas Penel, Christophe Perrin, Valérie Laurence, Emmanuelle Bompas, Esma Saâda-Bouzid, Corinne Delcambre, François Bertucci, Mathilde Cancel, Camille Schiffler, Laure Monard, Corinne Bouvier, Vincent Vidal, Nathalie Gaspar, Sylvie Chabaud	17
9	Cicaderma® in radiation–related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT 2023 ·Clinical and Translational Radiation Oncology ·S. Racadot, Antoine Arnaud, Camille Schiffler, (unknown), David Pérol, Youlia Kirova	2
10	Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score 2021 ·Radiotherapy and Oncology ·Esteban Brenet, (unknown), Camille Schiffler, P. Pommier, (unknown), Nazim Benzerdjeb, (unknown), Camille Boulagnon‐Rombi, Jean Ton Van, (unknown), S. Servagi-Vernat, X. Liem, Jean‐Claude Mérol, Philippe Céruse, (unknown), Sylvie Chabaud, M. Juliéron, Sophie Deneuve	4
11	LBA58 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer 2021 ·Annals of Oncology ·Florence Duffaud, Sylvie Chabaud, Christine Chevreau, Antoîne Italiano, Christophe Perrin, Nicolás Isambert, Sophie Piperno‐Neumann, Esma Saâda-Bouzid, François Bertucci, Didier Cupissol, Elsa Kalbacher, (unknown), Camille Schiffler, (unknown), Laure Monard, Corinne Bouvier, Vincent Vidal, Jean‐Yves Blay, Olivier Mir	2
12	Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening 2021 ·Journal of Neuro-Oncology ·(unknown), Marie Pierre Sunyach, Ronan Tanguy, Emmanuel Jouanneau, Camille Schiffler, (unknown), (unknown), Eve‐Marie Neidhardt, Helen Boyle, Sophie Robin, Sylvie Négrier, Aude Fléchon	3
13	LBA68 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER 2020 ·Annals of Oncology ·Florence Duffaud, Jean‐Yves Blay, Olivier Mir, Christine Chevreau, (unknown), Elsa Kalbacher, Nicolas Penel, Christophe Perrin, Valérie Laurence, Emmanuelle Bompas, Esma Saâda-Bouzid, Corinne Delcambre, François Bertucci, Mathilde Cancel, Camille Schiffler, Laure Monard, Corinne Bouvier, Vincent Vidal, Nathalie Gaspar, Sylvie Chabaud	13
14	Cryoneurolysis in Patients with Dorsal Neuropathic Pain Secondary to Tumor Invasion 2020 ·Journal of Vascular and Interventional Radiology ·(unknown), F. Pilleul, (unknown), (unknown), (unknown), (unknown), Camille Schiffler, Amine Bouhamama, Gisèle Chvetzoff, (unknown)	9
15	Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias 2020 ·Supportive Care in Cancer ·Didier Frappaz, Alice Bonneville-Levard, (unknown), Sean Carrie, Camille Schiffler, (unknown), Michael Weller	13
16	Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial 2019 ·BMC Infectious Diseases ·Clotilde El Guerche‐Séblain, Annick Moureau, Camille Schiffler, Martin Dupuy, Stéphanie Pépin, Sandrine Samson, Philippe Vanhems, François Schellevis	15
17	Very long‐term survivors among patients with metastatic soft tissue sarcoma 2019 ·Cancer Medicine ·(unknown), Mehdi Brahmi, Camille Schiffler, Pierre Méeus, Marie‐Pierre Sunyach, Amine Bouhamama, Marie Karanian, Franck Tirode, Daniel Pissaloux, Gualter Vaz, Isabelle Ray‐Coquard, Jean‐Yves Blay, Armelle Dufresne	13
18	mTORC1 activation assessed in metastatic sample to predict outcome in patients with metastatic breast cancer treated with everolimus-exemestan: Results from the SAFIRTOR study. 2019 ·Journal of Clinical Oncology ·Thomas Bachelot, Isabelle Treilleux, Camille Schiffler, Ivan Bièche, Mario Campone, Anne Patsouris, Mónica Arnedos, Paul Cottu, Jean-Philippe Jacquin, Florence Dalenc, Valéry Attignon, Étienne Rouleau, Alain Morel, (unknown), Marta Jimenez, Fabrice André	5
19	Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study breakdown → 2018 ·The Lancet Oncology ·Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette, Sophie Piperno‐Neumann, Nicolas Penel, Emmanuelle Bompas, Corinne Delcambre, Elsa Kalbacher, Antoîne Italiano, Olivier Collard, Christine Chevreau, Esma Saâda, Nicolás Isambert, Jessy Delaye, Camille Schiffler, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Jean‐Yves Blay	229
20	Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival 2017 ·British Journal of Cancer ·(unknown), Sylvie Chabaud, Jean‐Yves Pierga, Olivier Trédan, Étienne Brain, François‐Clément Bidard, Camille Schiffler, (unknown), (unknown), Isabelle Vilgrain, Thomas Bachelot	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact